Bone Biologics Corporation (BBLG) Financial Ratios
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
BBLG stock: frequently asked questions
What is BBLG's ST Score?
Bone Biologics Corporation (BBLG) has an ST Score of 48.5 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BBLG a buy, hold, or sell?
Our ST Score grades it C+ (48.5/100). The ST Score is a data-driven signal, not a recommendation.
What are BBLG's factor grades?
Valuation B-, Profitability C-, Financial Strength A-, Momentum D, Growth A+.
What is BBLG's valuation grade?
Bone Biologics Corporation (BBLG) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BBLG's growth grade?
Bone Biologics Corporation (BBLG) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BBLG's profitability grade?
Bone Biologics Corporation (BBLG) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BBLG's financial strength grade?
Bone Biologics Corporation (BBLG) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is BBLG's Piotroski score?
Bone Biologics Corporation (BBLG) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.